Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04599296 · ClinicalTrials.gov registry record · NA
Postoperative Hip Bracing After Hip Arthroscopy
A NA study of Femoroacetabular Impingement Syndrome and Acetabular Labral Tear, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 82
- Enrollment target
- 1
- Study location
NCT04599296: Completed NA study of Femoroacetabular Impingement Syndrome and Acetabular Labral Tear, sponsored by University of Washington.
NCT04599296 is a NA study of Femoroacetabular Impingement Syndrome and Acetabular Labral Tear that has completed, run by University of Washington. The registered enrollment target is 82 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04599296, a NA study of Femoroacetabular Impingement Syndrome and Acetabular Labral Tear, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 82 participants
- Enrollment target
- 1
- Study location
Study Summary
Hip arthroscopy for treatment of femoroacetabular impingement syndrome (FAIS) involves reshaping of the osseous sources of impingement ("osteoplasty") and treatment of impingement-associated labral tears with labral repair. Postoperative hip braces are advocated to decrease postoperative pain by offloading hip musculature. However there are no studies looking at efficacy of hip braces after hip arthroscopy, and on average 50% of high-volume hip arthroscopists use bracing. The objective of this study is to use a randomized controlled trial to test the cited benefits of postoperative hip bracing on short term patient reported pain scores, validated hip-specific pain scores, and physical exam findings of hip flexor tendonitis.
Primary Outcome
Validated pain scale, subject reported. Min 0, Max 10, Higher score means worse outcome.
Conditions Studied
Interventions
- DEVICE Hip brace
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2020-11-01 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
What the finished NCT04599296 record still lists
NCT04599296 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 82 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Femoroacetabular Impingement Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Hip brace is the first listed.
NCT04599296 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT04599296 about?
NCT04599296 is a clinical study titled "Postoperative Hip Bracing After Hip Arthroscopy". Hip arthroscopy for treatment of femoroacetabular impingement syndrome (FAIS) involves reshaping of the osseous sources of impingement ("osteoplasty") and treatment of impingement-associated labral tears with labral repair. Postoperative hip braces are advocated to decrease postoperative pain by off...
What is the current status of trial NCT04599296?
This trial is currently completed. It is a NA study. The enrollment target is 82 participants. The study started on 2020-11-01. Estimated completion is 2023-12-31.
What conditions does trial NCT04599296 study?
This clinical trial studies the following conditions: Femoroacetabular Impingement Syndrome, Acetabular Labral Tear.
What interventions are being tested in trial NCT04599296?
The interventions under investigation include: Hip brace (DEVICE).
Who is sponsoring clinical trial NCT04599296?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04599296 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Femoroacetabular Impingement Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04599296's enrollment target sits among peer trials
82 990th of 2000 higher than 1,009 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03319901 · 82 participants · Phase 1
Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL
- NCT03493425 · 82 participants · Phase 2
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery
- NCT04105270 · 82 participants · Phase 2
RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
- NCT04428658 · 82 participants · NA
Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI